Market Overview

Morgan Stanley Comments on Takeaways from athenahealth Investor Day

Related ATHN
Omnicell Raised to Strong Buy - Analyst Blog
Cerner to Offer OTTR Solutions - Analyst Blog

In a report published Friday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Equal-Weight rating on athenahealth (NASDAQ: ATHN).

In the report, Morgan Stanley noted, “Rather than directly pursue inpatient EHR or Population Health replacements, ATHN is looking to embed itself in the workflow of hospitals by performing pre-certification and pre-registration work for patient referral orders entered through its Clinicals installed base. Coordinator referral capabilities will also be built into the Epocrates app along with a mobile version of ATHN's EMR. The goal is to expand brand awareness and perception of ATHN in hospitals and large physician groups, enabling easier enterprise deal wins.”

athenahealth closed on Thursday at $130.85.

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Reiteration Analyst Ratings

 

Most Popular

Related Articles (ATHN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free